SML3803
Gabapentin Enacarbil
≥95% (HPLC)
别名:
1-[[(1-(Isobutanoyloxy)ethoxy)carbonyl]aminomethyl]cyclohex-1-ylacetic acid, 1-[[[[1-(2-Methyl-1-oxopropoxy)ethoxy]carbonyl]amino]methyl]cyclohexaneacetic acid, XP 13512
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C16H27NO6
化学文摘社编号:
分子量:
329.39
UNSPSC Code:
12352200
NACRES:
NA.21
MDL number:
Quality Level
assay
≥95% (HPLC)
form
oil
color
, Faint yellow to dark yellow
storage temp.
2-8°C
SMILES string
N(CC1(CCCCC1)CC(=O)O)C(=O)OC(OC(=O)C(C)C)C
InChI
1S/C16H27NO6/c1-11(2)14(20)22-12(3)23-15(21)17-10-16(9-13(18)19)7-5-4-6-8-16/h11-12H,4-10H2,1-3H3,(H,17,21)(H,18,19)
InChI key
TZDUHAJSIBHXDL-UHFFFAOYSA-N
Biochem/physiol Actions
Gabapentin enacarbil, a prodrug to gabapentin, is an orally available anticonvulsant and analgesic drug of the gabapentinoid class. Gabapentin enacarbil is used for treatment of restless legs syndrome.
Orally available anticonvulsant and analgesic drug; prodrug to gabapentin
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
XP13512 [(+/-)-1-([(alpha-isobutanoyloxyethoxy)carbonyl] aminomethyl)-1-cyclohexane acetic acid], a novel gabapentin prodrug: II. Improved oral bioavailability, dose proportionality, and colonic absorption compared with gabapentin in rats and monkeys
Journal of Pharmacology and Experimental Therapeutics, 311(1), 324-333 (2004)
Non-dopaminergic vs. dopaminergic treatment options in restless legs syndrome
Advances in Pharmacology, 84, 187-205 (2019)
Satomi Yamaguchi Ikeuchi et al.
Biological & pharmaceutical bulletin, 41(11), 1708-1715 (2018-11-02)
The purpose of this research was to establish an in vitro dissolution testing method to predict the oral pharmacokinetic (PK) profiles and food effects of gabapentin enacarbil formulated as wax matrix extended-release (ER) tablets in humans. We adopted various biorelevant
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| SML3803-5MG | 04065270217776 |
| SML3803-25MG | 04065270217769 |